Sun Pharma gets DCGI nod to launch generic semaglutide for weight management

Sun Pharma has gained the green light from the DCGI for its much-anticipated generic version of semaglutide injection, targeting chronic weight management under the name Noveltreat. With Novo Nordisk's patent expiration on the horizon, this initiative marks a pivotal moment in accessible healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9YVxW2L
via IFTTT